Be Kind to Your Genes: An Insurance Perspective on the Fast-Growing Field of Epigenetics
Eat your vegetables. Stay active. Avoid smoking. Keep out of the sun. Patients have been hearing this good advice from their doctors for a long time. Now, researchers are uncovering new evidence that our lifestyle choices can measurably influence mortality risk at a genetic level. Learn more about the emerging science of epigenetics in a two-part interview and the webinar “Epigenetics and Liquid Biopsies: Fact, Fiction or Both.”
SCOR Housecalls: Chronic Granulomatous Disease
What is Chronic Granulomatous Disease, and what are the mortality implications?
LexisNexis Risk Classifier – Stratifying Mortality Risk Using Alternative Data Sources
Munich Re assessed LexisNexis Risk Classifier, a predictive modeling tool developed and owned by LexisNexis Risk Solutions, Inc. that accurately stratifies mortality risk using public records, consumer credit history and motor vehicle history. Insurers considering alternative data-based mortality scores should begin with a retrospective validation study on their own experience data.
Cancer Deaths Fall to Lowest Rate in Decades as Smoking Declines
Fewer Americans are getting cancer, and more of those who do are surviving the disease, according to a new study.
Cancer Risks: Are We Getting Them Right?
Researching cancer mortality over the past few months has proved to be a bit of an eye-opener, and in three ways: firstly the level of excess mortality seen in a number of cancers, secondly the duration over which an extra risk persists, and thirdly that excess mortality may extend over a considerable period.
Risk Assessment of Non-Metastatic Breast Cancer in the Genomic Era
Underwriting breast cancer in 2017 will require an understanding of the current and growing role of genomics in the assessment of its mortality risk. This is not to lessen the importance of well-known prognosticators such as tumor/node/metastasis (TNM) staging, estrogen receptor/progesterone receptor (ER/PR) and human epidermal receptor growth factor 2 (HER2) receptor status, grade, or the mitotic activity index (MAI). Rather, it is to keep abreast of additional genomics-based prognostic tools that can be used to further stratify breast cancer and its risks.
Wearables in Life Insurance – Game Changer or Passing Fad?
Some life insurers now use data from fitness trackers to lower premiums. But does a policyholder’s number of steps really improve his or her mortality? Despite the link between a sedentary life and the risk of heart disease or cancer being well known, there is no consensus on how many daily steps reduce this risk.
Study Shows Link between Debt and Mortality Rates
A new study from the University of Colorado Denver shows a direct link between financial strain and increased risk of death, a finding with potentially major implications for both economic and health care policy.